Literature DB >> 20062085

Thyroid hormone receptors are tumor suppressors in a mouse model of metastatic follicular thyroid carcinoma.

X-G Zhu1, L Zhao, M C Willingham, S-Y Cheng.   

Abstract

Aberrant expression and mutations of thyroid hormone receptor genes (TRs) are closely associated with several types of human cancers. To test the hypothesis that TRs could function as tumor suppressors, we took advantage of mice with deletion of all functional TRs (TRalpha1(-/-)TRbeta(-/-) mice). As these mice aged, they spontaneously developed follicular thyroid carcinoma with pathological progression from hyperplasia to capsular invasion, vascular invasion, anaplasia and metastasis to the lung, similar to human thyroid cancer. Detailed molecular analysis revealed that known tumor promoters such as pituitary tumor-transforming gene were activated and tumor suppressors such as peroxisome proliferator-activated receptor gamma and p53 were suppressed during carcinogenesis. In addition, consistent with the human cancer, AKT-mTOR-p70(S6K) signaling and vascular growth factor and its receptor were activated to facilitate tumor progression. This report presents in vivo evidence that functional loss of both TRalpha1 and TRbeta genes promotes tumor development and metastasis. Thus, TRs could function as tumor suppressors in a mouse model of metastatic follicular thyroid cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20062085      PMCID: PMC3443884          DOI: 10.1038/onc.2009.476

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  63 in total

Review 1.  Resistance to thyroid hormone.

Authors:  R E Weiss; S Refetoff
Journal:  Rev Endocr Metab Disord       Date:  2000-01       Impact factor: 6.514

Review 2.  Matrix metalloproteinases: a tail of a frog that became a prince.

Authors:  Constance E Brinckerhoff; Lynn M Matrisian
Journal:  Nat Rev Mol Cell Biol       Date:  2002-03       Impact factor: 94.444

3.  A pituitary tumor in a patient with thyroid hormone resistance: a diagnostic dilemma.

Authors:  J D Safer; S D Colan; L M Fraser; F E Wondisford
Journal:  Thyroid       Date:  2001-03       Impact factor: 6.568

4.  The c-erb-A protein is a high-affinity receptor for thyroid hormone.

Authors:  J Sap; A Muñoz; K Damm; Y Goldberg; J Ghysdael; A Leutz; H Beug; B Vennström
Journal:  Nature       Date:  1986 Dec 18-31       Impact factor: 49.962

5.  Variable transcriptional activity and ligand binding of mutant beta 1 3,5,3'-triiodothyronine receptors from four families with generalized resistance to thyroid hormone.

Authors:  C A Meier; B M Dickstein; K Ashizawa; J H McClaskey; P Muchmore; S C Ransom; J B Menke; E H Hao; S J Usala; B B Bercu
Journal:  Mol Endocrinol       Date:  1992-02

6.  Thyroid hormone receptor beta1 acts as a potent suppressor of tumor invasiveness and metastasis.

Authors:  Olaia Martínez-Iglesias; Susana Garcia-Silva; Stephan P Tenbaum; Javier Regadera; Fernando Larcher; Jesus M Paramio; Bjorn Vennström; Ana Aranda
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

7.  Alterations in genomic profiles during tumor progression in a mouse model of follicular thyroid carcinoma.

Authors:  Hao Ying; Hideyo Suzuki; Hiroko Furumoto; Robert Walker; Paul Meltzer; Mark C Willingham; Sheue-Yann Cheng
Journal:  Carcinogenesis       Date:  2003-07-17       Impact factor: 4.944

8.  Oncogenic potential of guanine nucleotide stimulatory factor alpha subunit in thyroid glands of transgenic mice.

Authors:  F M Michiels; B Caillou; M Talbot; F Dessarps-Freichey; M T Maunoury; M Schlumberger; L Mercken; R Monier; J Feunteun
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

Review 9.  Nongenomic activation of phosphatidylinositol 3-kinase signaling by thyroid hormone receptors.

Authors:  Fumihiko Furuya; Changxue Lu; Celine J Guigon; Sheue-Yann Cheng
Journal:  Steroids       Date:  2008-10-30       Impact factor: 2.668

10.  Thyroid expression of an A2 adenosine receptor transgene induces thyroid hyperplasia and hyperthyroidism.

Authors:  C Ledent; J E Dumont; G Vassart; M Parmentier
Journal:  EMBO J       Date:  1992-02       Impact factor: 11.598

View more
  20 in total

Review 1.  Thyroid hormone receptors and cancer.

Authors:  Won Gu Kim; Sheue-yann Cheng
Journal:  Biochim Biophys Acta       Date:  2012-04-06

2.  Recruitment of the oncoprotein v-ErbA to aggresomes.

Authors:  Cornelius Bondzi; Abigail M Brunner; Michelle R Munyikwa; Crystal D Connor; Alicia N Simmons; Stephanie L Stephens; Patricia A Belt; Vincent R Roggero; Manohara S Mavinakere; Shantá D Hinton; Lizabeth A Allison
Journal:  Mol Cell Endocrinol       Date:  2010-11-12       Impact factor: 4.102

3.  Hepatic FOXO1 Target Genes Are Co-regulated by Thyroid Hormone via RICTOR Protein Deacetylation and MTORC2-AKT Protein Inhibition.

Authors:  Brijesh K Singh; Rohit A Sinha; Jin Zhou; Madhulika Tripathi; Kenji Ohba; Mu-En Wang; Inna Astapova; Sujoy Ghosh; Anthony N Hollenberg; Karine Gauthier; Paul M Yen
Journal:  J Biol Chem       Date:  2015-10-09       Impact factor: 5.157

4.  Reduced expression of THRβ in papillary thyroid carcinomas: relationship with BRAF mutation, aggressiveness and miR expression.

Authors:  F Rosignolo; V Maggisano; M Sponziello; M Celano; C R T Di Gioia; M D'Agostino; L Giacomelli; A Verrienti; M Dima; V Pecce; C Durante
Journal:  J Endocrinol Invest       Date:  2015-05-24       Impact factor: 4.256

5.  Mutant thyroid hormone receptors (TRs) isolated from distinct cancer types display distinct target gene specificities: a unique regulatory repertoire associated with two renal clear cell carcinomas.

Authors:  Meghan D Rosen; Ivan H Chan; Martin L Privalsky
Journal:  Mol Endocrinol       Date:  2011-05-26

6.  Global expression profiling reveals gain-of-function oncogenic activity of a mutated thyroid hormone receptor in thyroid carcinogenesis.

Authors:  Changxue Lu; Alok Mishra; Yuelin J Zhu; Paul Meltzer; Sheue-Yann Cheng
Journal:  Am J Cancer Res       Date:  2011       Impact factor: 6.166

7.  Modeling follicular thyroid cancer for future therapies.

Authors:  Xuguang Zhu; Sheue-Yann Cheng
Journal:  Am J Cancer Res       Date:  2012-02-15       Impact factor: 6.166

8.  Role of TSH in the spontaneous development of asymmetrical thyroid carcinoma in mice with a targeted mutation in a single allele of the thyroid hormone-β receptor.

Authors:  Li Zhao; Xuguang Zhu; Jeong Won Park; Laura Fozzatti; Mark Willingham; Sheue-yann Cheng
Journal:  Endocrinology       Date:  2012-08-23       Impact factor: 4.736

9.  Inhibition of tumorigenesis by the thyroid hormone receptor β in xenograft models.

Authors:  Won Gu Kim; Li Zhao; Dong Wook Kim; Mark C Willingham; Sheue-yann Cheng
Journal:  Thyroid       Date:  2013-09-04       Impact factor: 6.568

10.  An in vivo mouse model of metastatic human thyroid cancer.

Authors:  Lisa Zhang; Kelli Gaskins; Zhiya Yu; Yin Xiong; Maria J Merino; Electron Kebebew
Journal:  Thyroid       Date:  2014-03-10       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.